| Associated Funds |
Form D |
Role |
2011 - 2026 |
Raised |
AUM |
| Blackstone Life Sciences Advisors LLC |
| Blackstone Life Sciences VI - BL LP |
021-564548
|
Executive Officer |
|
3,615.3 M |
88.2 M |
| Blackstone Life Sciences VI - B LP |
021-564546
|
Executive Officer |
|
3,615.3 M |
163.0 M |
| Blackstone Life Sciences VI LP |
021-532359
|
Executive Officer |
|
3,615.3 M |
3,762.6 M |
| Blackstone Life Sciences VI Lux SCSP |
021-532387
|
Executive Officer |
|
3,615.3 M |
372.8 M |
| Blackstone Life Sciences Yield LP |
021-413640
|
Executive Officer |
|
1,642.4 M of 1,642.4 M |
376.5 M |
| Blackstone Life Sciences Yield NT LP |
021-413656
|
Executive Officer |
|
1,642.4 M of 1,642.4 M |
859.4 M |
| Blackstone Life Sciences Yield T LP |
021-413688
|
Executive Officer |
|
1,642.4 M of 1,642.4 M |
383.2 M |
|
| Blackstone Trident Partners LP |
021-554424
|
Executive Officer |
|
|
|
| Blackstone Radar Partners CYM LP |
021-548485
|
Executive Officer |
|
|
|
| Blackstone Burgundy Partners CYM Feeder LP |
021-530446
|
Executive Officer |
|
|
|
| Blackstone Burgundy Partners LP |
021-530434
|
Executive Officer |
|
|
|
| Blackstone Fireworks Partners CYM Feeder LP |
021-507802
|
Executive Officer |
|
|
|
| Blackstone Fireworks Partners LP |
021-496445
|
Executive Officer |
|
|
|
| Blackstone F-Eleven Partners LP |
021-470532
|
Executive Officer |
|
|
|
| Blackstone Intrepid Partners CYM Feeder LP |
021-469318
|
Executive Officer |
|
|
|
| Praxis Precision Medicines Inc |
021-342943
|
Director |
|
10.0 M of 10.0 M |
|
| Praxis Precision Medicines Inc |
021-308540
|
Director |
|
18.8 M of 46.4 M |
|
| Praxis Precision Medicines Inc |
021-274221
|
Director |
|
3.1 M of 7.7 M |
|
| Catabasis Pharmaceuticals Inc |
021-236973
|
Director |
|
12.4 M of 20.4 M |
|
| Clarus Ventures III GP LP |
021-225116
|
Executive Officer |
|
of 50.0 M |
|
| Catabasis Pharmaceuticals Inc |
021-206457
|
Director |
|
32.4 M of 32.4 M |
|
| Ophthotech Corp |
021-197362
|
Director |
|
16.7 M of 50.0 M |
|
| NanoString Technologies Inc |
021-196355
|
Director |
|
0.1 M of 0.1 M |
|
| Ophthotech Corp |
021-193562
|
Director |
|
0.0 M of 0.0 M |
|
| Catabasis Pharmaceuticals Inc |
021-191213
|
Director |
|
9.2 M of 9.2 M |
|
| NanoString Technologies Inc |
021-189901
|
Director |
|
of 0.3 M |
|
| Ophthotech Corp |
021-189331
|
Director |
|
0.0 M of 0.0 M |
|
| NanoString Technologies Inc |
021-188835
|
Director |
|
0.3 M of 0.3 M |
|
| NanoString Technologies Inc |
021-188246
|
Director |
|
15.3 M of 15.3 M |
|
| Ophthotech Corp |
021-180685
|
Director |
|
0.0 M of 0.0 M |
|
| NanoString Technologies Inc |
021-176639
|
Director |
|
of 0.6 M |
|
| Portola Pharmaceuticals Inc |
021-170477
|
Director |
|
9.0 M of 9.0 M |
|
| Portola Pharmaceuticals Inc |
021-169528
|
Director |
|
89.0 M of 90.0 M |
|
| NanoString Technologies Inc |
021-168616
|
Director |
|
20.0 M of 25.0 M |
|
| NanoString Technologies Inc |
021-162038
|
Director |
|
2.5 M of 14.0 M |
|
| Aveo Pharmaceuticals Inc |
021-160532
|
Director |
|
7.5 M of 7.5 M |
|
| Aerovance Inc |
021-157015
|
Director |
|
0.5 M of 1.6 M |
|
| NanoString Technologies Inc |
021-150837
|
Director |
|
of 0.1 M |
|
| Aveo Pharmaceuticals Inc |
021-149990
|
Director |
|
60.8 M of 60.8 M |
|
| Aerovance Inc |
021-147949
|
Director |
|
2.0 M of 7.5 M |
|
| Ophthotech Corp |
021-107978
|
Director |
|
15.0 M of 30.0 M |
|
| NanoString Technologies Inc |
021-103930
|
Director |
|
of 0.0 M |
|
| Portola Pharmaceuticals Inc |
021-59981
|
Director |
|
60.1 M of 60.1 M |
|
| Taligen Therapeutics Inc |
021-80731
|
Director |
|
36.0 M of 65.0 M |
|
| Aveo Pharmaceuticals Inc |
021-76653
|
Director |
|
30.0 M of 60.0 M |
|
| Affymax Inc |
021-55801
|
Director |
|
42.0 M of 42.0 M |
|
| Clarus Ventures LLC |
| Clarus IV-A LP |
021-286937
|
Executive Officer |
|
789.7 M of 880.0 M |
217.3 M |
| Clarus IV-B LP |
021-286939
|
Executive Officer |
|
789.7 M of 880.0 M |
139.5 M |
| Clarus IV-C LP |
021-286940
|
Executive Officer |
|
789.7 M of 880.0 M |
257.5 M |
| Clarus IV-D LP |
021-286941
|
Executive Officer |
|
789.7 M of 880.0 M |
51.4 M |
| Clarus Defined Exit I LP |
021-222299
|
Executive Officer |
|
100.0 M of 100.0 M |
63.9 M |
| Clarus de II LP |
021-224951
|
Executive Officer |
|
40.0 M of 40.0 M |
26.8 M |
| Clarus Lifesciences III LP |
021-211426
|
Executive Officer |
|
234.2 M of 375.0 M |
24.8 M |